Literature DB >> 8839550

The prognostic significance of vascular invasion by endometrial carcinoma.

Y Inoue1, K Obata, K Abe, G Ohmura, K Doh, T Yoshioka, H Hoshiai, K Noda.   

Abstract

BACKGROUND: Recently, invasion of vascular spaces by endometrial carcinoma has received particular attention as a prognostic factor. The goal of the current investigation was to re-examine the effect of vascular invasion on tumor recurrence and survival in patients with endometrial carcinoma.
METHODS: Surgical specimens from 238 patients with endometrial carcinoma were examined for the presence of vascular invasion by tumor cells. Vascular invasion was compared with clinicopathologic features and postoperative survival. Survival curves by vascular invasion were evaluated by the Kaplan-Meier method.
RESULTS: In a histopathologic review of 238 cases of endometrial carcinoma, 82 neoplasms demonstrated vascular invasion. Vascular invasion significantly correlated with the extension of primary tumor, depth of myometrial invasion, and histologic grade. Patients with lymph node metastasis had a significantly higher incidence of vascular invasion. Survival at 5 years for patients with vascular invasion was 73.4%. This was significantly lower than the survival rate of 91.5% for women without this finding (P < 0.001). Among patients with lymph node metastasis, 80.2% of the patients with vascular invasion survived for 5 years compared with 95.3% of the patients without vascular invasion (P < 0.05). Ten of 47 patients with no lymph node metastasis but with vascular invasion developed recurrent carcinoma. Nine of these ten patients apparently had extrapelvic recurrences.
CONCLUSIONS: The presence of vascular invasion is a reliable prognostic indicator. Recording of tumor recurrence pattern may lead to a better selection of patients for adjuvant systemic therapy after surgery.

Entities:  

Mesh:

Year:  1996        PMID: 8839550     DOI: 10.1002/(SICI)1097-0142(19961001)78:7<1447::AID-CNCR11>3.0.CO;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry.

Authors:  F Alexander-Sefre; N Singh; A Ayhan; H B Salveson; G Wilbanks; I J Jacobs
Journal:  J Clin Pathol       Date:  2003-10       Impact factor: 3.411

2.  Treatment of pure uterine sarcoma at the Institut Català D'Oncologia.

Authors:  Gonçalo Fernandez; Susanna Marín I Borràs; Valentín Navarro Pérez; Ferran Guedea
Journal:  Rep Pract Oncol Radiother       Date:  2013-01-16

Review 3.  The role of para-aortic lymphadenectomy in endometrial cancer.

Authors:  Mariam M AlHilli; Andrea Mariani
Journal:  Int J Clin Oncol       Date:  2013-02-15       Impact factor: 3.402

4.  Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy.

Authors:  Candan Demiroz Abakay; Sonay Arslan; Meral Kurt; Sibel Cetintas
Journal:  Radiat Oncol J       Date:  2022-05-25

5.  Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer.

Authors:  Soledad Jorge; June Y Hou; Ana I Tergas; William M Burke; Yongmei Huang; Jim C Hu; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2016-01-06       Impact factor: 5.482

6.  High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome.

Authors:  Gustavo A Viani; Barbara F Patia; Antonio C Pellizzon; Marcel D De Melo; Paulo E Novaes; Ricardo C Fogaroli; Maria A Conte; Joao V Salvajoli
Journal:  Radiat Oncol       Date:  2006-08-03       Impact factor: 3.481

7.  Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion.

Authors:  Haider Mahdi; Amelia Jernigan; Benjamin Nutter; Chad Michener; Peter G Rose
Journal:  J Gynecol Oncol       Date:  2015-01-26       Impact factor: 4.401

8.  Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer.

Authors:  L Helpman; R Kupets; A Covens; R S Saad; M A Khalifa; N Ismiil; Z Ghorab; V Dubé; S Nofech-Mozes
Journal:  Br J Cancer       Date:  2013-12-24       Impact factor: 7.640

9.  The prognostic significance of tumor lymphangiogenesis and lymphatic vessel density in endometrioid carcinoma of the uterine corpus.

Authors:  Mika Sakaki; Masanori Yasuda; Mitsutake Yano; Yoshiya Goto; Masaru Nakamura; Hidekazu Kayano; Kosei Hasegawa
Journal:  Oncol Lett       Date:  2017-09-04       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.